SCHEMBL8636703

SCHEMBL8636703

NC(=O)c1cc(N(CCBr)CCBr)c([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
CYP3A4 P08684 2/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
HCAR3 P49019 4/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH3A1 P30838 1/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
PARP1 P09874 1/20 0.34
KMT2A Q03164 1/20 0.34
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
MITF O75030 2/20 0.33
HTT P42858 1/20 0.32
CCR6 P51684 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421496 0.95 MAPT (0.46) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL2970718 0.94 MAPT (0.45) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL13202973 0.94 MAPT (0.45) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL3983950 0.92 MAPT (0.46) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL17191294 0.88 MAPT (0.44) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL3590337 0.87 HCAR3 (0.47) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL2966410 0.86 MAPT (0.39) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL8639061 0.86 MAPT (0.47) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL29411996 0.86 MAPT (0.47) MAPTCYP3A4BLMPMP22HCAR3
SCHEMBL2364159 0.86 MAPT (0.47) MAPTCYP3A4BLMPMP22HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0558104-B1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO WELLCOME SPA (IT) 1998-07-29 EP disclosed
EP-0616609-B1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RES CAMPAIGN TECH (GB) 1997-06-18 EP disclosed
US-5637697-A ANTAGONIST TO GASTRIN AND(OR) CHLOROCYSTOKININ GLAXO SPA (IT) 1997-06-10 US disclosed
US-5580895-A GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS GLAXO SPA (IT) 1996-12-03 US disclosed
US-5571845-A Nitroaniline derivatives and their use as anti-tumour agents CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-11-05 US disclosed
EP-0616609-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS. CANCER RES CAMPAIGN TECH (GB) 1994-09-28 EP disclosed
EP-0558104-A1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO S.p.A. (IT) 1993-09-01 EP disclosed
WO-1993014074-A1 1,5-BENZODIAZEPINE DERIVATIVES AND THEIR USE IN MEDICINE GLAXO SPA (IT) 1993-07-22 WO disclosed
WO-1993011099-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1993-06-10 WO disclosed